Condition
Cancer-Related Anemia
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Ferrous Succinate
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 2 (1)
Phase 3 (1)
Trial Status
Not Yet Recruiting1
Unknown1
Clinical Trials (2)
Research Network
Common Treatments
- Ferrous Succinate1
- Shengxuening Tablet1
- And0171
Active Sponsors
- Kind Pharmaceuticals LLC1
- Zhongnan Hospital1
Top Investigators
Kind Pharmaceuticals LLC
Related Conditions
- Hematological Malignancy1